Finance

Lists
300233:SHE
Shandong Jincheng Pharmacetcl Grp Co Ltd
CNÂ¥13.12
-0.30%
(-0.040) 1D
Sep 4, 3:04:01 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300233...
Open
CNÂ¥13.28
High
CNÂ¥13.40
Low
CNÂ¥13.08
Mkt. cap
5.13B
Avg. vol.
11.42M
Volume
7.33M
Dividend
1.91%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
May 15, 2026
P/E ratio
34.04
52-wk high
CNÂ¥22.47
52-wk low
CNÂ¥11.58
EPS
CNÂ¥0.39
Shares outstanding
383.87M
No. of employees
4K
Open
CNÂ¥13.28
High
CNÂ¥13.40
Low
CNÂ¥13.08
Mkt. cap
5.13B
Avg. vol.
11.42M
Volume
7.33M
Dividend
1.91%
Quarterly dividend
CNÂ¥0.06
Ex-dividend date
May 15, 2026
P/E ratio
34.04
52-wk high
CNÂ¥22.47
52-wk low
CNÂ¥11.58
EPS
CNÂ¥0.39
Shares outstanding
383.87M
No. of employees
4K
About Shandong Jincheng Pharmacetcl Grp Co Ltd
CEO-
Employees3.52K
FoundedJan 12, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
571.78M
804.90M
750.42M
696.82M
Cost of goods sold
335.86M
580.35M
490.69M
455.05M
Cost of revenue
335.86M
580.35M
490.69M
455.05M
Research and development expenses
37.92M
76.63M
37.92M
40.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
188.66M
101.14M
131.61M
142.17M
Operating expense
214.54M
211.31M
174.47M
194.49M
Total operating expenses
550.40M
791.65M
665.16M
649.55M
Operating income
21.39M
13.25M
85.27M
47.28M
Other non operating income
-2.75M
2.32M
-3.24M
2.81M
EBT including unusual items
-9.21M
27.44M
76.16M
97.22M
EBT excluding unusual items
15.96M
15.75M
81.89M
65.64M
Income tax expense
2.16M
18.77M
17.15M
14.74M
Effective tax rate
-23.47%
68.39%
22.51%
15.16%
Other operating expenses
-4.63M
20.94M
4.07M
13.50M
Net income
-11.81M
12.61M
57.79M
81.08M
Net profit margin
-2.06%
1.57%
7.70%
11.64%
Earnings per share
-
-
-
-
Interest and investment income
1.48M
2.99M
1.86M
24.10M
Interest expense
-2.47M
-2.29M
-1.99M
-2.03M
Net interest expenses
-992.40K
707.51K
-131.57K
22.07M
Depreciation and amortization charges
-
-
-
-
EBITDA
100.60M
93.00M
165.01M
127.07M
Gain or loss from assets sale
388.85K
-2.95M
-
-47.83M
AI content may include mistakes. Learn more
Google apps